Socialiya - Entertainment. Knowledge. Community.
Exclusive | FDA Gives Third Rare-Disease Drug Another Shot, Regenxbio Says

Company plans to refile its application for its gene therapy for a fatal brain disease after FDA dro...

BUSINESS NEWS June 22, 2026

Exclusive | FDA Gives Third Rare-Disease Drug Another Shot, Regenxbio Says

Company plans to refile its application for its gene therapy for a fatal brain disease after FDA dropped demands to give a placebo to some study subjects.

2 views 0 likes 0 comments
Share:
Company plans to refile its application for its gene therapy for a fatal brain disease after FDA dropped demands to give a placebo to some study subjects.

Related News

Advertisement
APNA POS
Advertisement
socialiya
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
APNA POS
Advertisement
socialiya
Advertisement
APNA POS